The global market for CAR T-cell therapy in treating Non-Hodgkin's lymphoma is witnessing substantial growth. This phenomenon is fueled by several factors, including rising prevalence of Non-Hodgkin's lymphoma, developments in CAR T-cell therapy technology, and expanding acceptance by healthcare providers. The market is divided based on factors suc… Read More